Literature DB >> 8603359

Upregulated expression of the genes encoding translation initiation factors eIF-4E and eIF-2alpha in transformed cells.

I B Rosenwald1.   

Abstract

Increased protein synthesis is necessary for the transition of cells from quiescence to proliferation. It is shown in this paper that the induction of expression of the translation initiation factor eIF-4E in normal cells requires serum growth factors, while this requirement is abrogated in tumor cells analyzed in this study. Further, the expression of eIF-4E and eIF-2alpha is increased in c-myc, v-src, and v-abl-transformed cells. It is demonstrated that an increase in c-myc function leads to elevated expression of eIF-4E and eIF-2alpha, increases in net protein synthesis and cell proliferation. It may be suggested that constitutive activation of translational machinery may be one common mechanism by which various oncogenes exert their transforming function.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8603359     DOI: 10.1016/0304-3835(96)04171-7

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  16 in total

Review 1.  RNA polymerase III transcription: its control by tumor suppressors and its deregulation by transforming agents.

Authors:  T R Brown; P H Scott; T Stein; A G Winter; R J White
Journal:  Gene Expr       Date:  2000

2.  Emerging therapeutics targeting mRNA translation.

Authors:  Abba Malina; John R Mills; Jerry Pelletier
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-04-01       Impact factor: 10.005

Review 3.  Translational regulation in nutrigenomics.

Authors:  Botao Liu; Shu-Bing Qian
Journal:  Adv Nutr       Date:  2011-11-03       Impact factor: 8.701

4.  Cell cycle progression and proliferation despite 4BP-1 dephosphorylation.

Authors:  S O Marx; A R Marks
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

5.  Expression of the eukaryotic translation initiation factors 4E and 2alpha in non-Hodgkin's lymphomas.

Authors:  S Wang; I B Rosenwald; M J Hutzler; G A Pihan; L Savas; J J Chen; B A Woda
Journal:  Am J Pathol       Date:  1999-07       Impact factor: 4.307

6.  Curcumin modulates eukaryotic initiation factors in human lung adenocarcinoma epithelial cells.

Authors:  Lixia Chen; Guoqing Tian; Changxia Shao; Everardo Cobos; Weimin Gao
Journal:  Mol Biol Rep       Date:  2009-10-15       Impact factor: 2.316

7.  Cell death/proliferation roles for nc886, a non-coding RNA, in the protein kinase R pathway in cholangiocarcinoma.

Authors:  N Kunkeaw; S H Jeon; K Lee; B H Johnson; S Tanasanvimon; M Javle; C Pairojkul; Y Chamgramol; W Wongfieng; B Gong; C Leelayuwat; Y S Lee
Journal:  Oncogene       Date:  2012-08-27       Impact factor: 9.867

8.  Novel regulatory factors interacting with the promoter of the gene encoding the mRNA cap binding protein (eIF4E) and their function in growth regulation.

Authors:  K A Johnston; M Polymenis; S Wang; J Branda; E V Schmidt
Journal:  Mol Cell Biol       Date:  1998-10       Impact factor: 4.272

9.  Reduced eukaryotic initiation factor 2Bepsilon-subunit expression suppresses the transformed phenotype of cells overexpressing the protein.

Authors:  James W Gallagher; Neil Kubica; Scot R Kimball; Leonard S Jefferson
Journal:  Cancer Res       Date:  2008-11-01       Impact factor: 12.701

10.  PERK regulates the proliferation and development of insulin-secreting beta-cell tumors in the endocrine pancreas of mice.

Authors:  Sounak Gupta; Barbara McGrath; Douglas R Cavener
Journal:  PLoS One       Date:  2009-11-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.